Analyst Rating Update on CVS Health Corporation (CVS)

CVS Health Corporation (CVS) : 21 analysts are covering CVS Health Corporation (CVS) and their average rating on the stock is 1.48, which is read as a Strong Buy. 15 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. CVS Health Corporation (CVS) also receives 2 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 4 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

CVS Health Corporation (CVS) : The most positive equity analysts on CVS Health Corporation (CVS) expects the shares to touch $123, whereas, the least positive believes that the stock will trade at $90 in the short term. The company is covered by 22 Wall Street Brokerage Firms. The average price target for shares are $111.68 with an expected fluctuation of $8.19 from the mean.

For the current week, the company shares have a recommendation consensus of Buy. Also, In the latest statement by the brokerage house, Morgan Stanley downgrades its outlook on CVS Health Corporation (NYSE:CVS). The current rating of the shares is Equal-weight, according to the research report released by the firm. The brokerage firm lowers the price target from $111 per share to $104 per share. The rating by the firm was issued on June 20, 2016.


CVS Health Corporation (NYSE:CVS): The stock opened at $97.70 on Wednesday but the bulls could not build on the opening and the stock topped out at $97.99 for the day. The stock traded down to $96.96 during the day, due to lack of any buying support eventually closed down at $97.43 with a loss of -0.64% for the day. The stock had closed at $98.06 on the previous day. The total traded volume was 6,236,882 shares.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.